Biomonitoring and biomarker-guided therapy: The next step in heart failure and biomarker research

Journal of the American College of Cardiology

Volumn 58, Issue 18, 2011, Pages 1890-1892

  Maisel, Alan ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

heart failure; natriuretic peptides; outcomes

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ARGIPRESSIN; ARGIPRESSIN ANTAGONIST; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; COPEPTIN; PEPTIDE HORMONE ANTAGONIST; PLACEBO; SODIUM; TOLVAPTAN; TROPONIN; TROPONIN I; UNCLASSIFIED DRUG; VASOPRESSIN;

BIOLOGICAL MONITORING; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE VOLUME; HUMAN; HYPONATREMIA; NOTE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN TARGETING; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; THERAPY EFFECT;

EID: 80054985847     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.07.032     Document Type: Editorial

References (18)

1. A. Maisel Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design? J Am Coll Cardiol 55 2009 61 64
2. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2009 53 60
3. A. Maisel, J.E. Hollander, and D. Guss Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 2004 1328 1333 (Pubitemid 39208893)
4. R. Kazanegra, V. Cheng, and A. Garcia A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 7 2001 21 29 (Pubitemid 32285185)
5. A. Maisel, C. Mueller, and K. Adams Jr. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
6. J.L. Januzzi Jr., S.U. Rehman, and A.A. Mohammed Use of amino-terminal proB-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
7. G.M. Felker, V. Hasselblad, A.F. Hernandez, and C.M. O'Connor Biomarker guided therapy in chronic heart failure: a metaanalysis of randomized, controlled trials Am Heart J 158 2009 423 430
8. A. Maisel The coming of age of natriuretic peptidesthe emperor does have clothes! J Am Coll Cardiol 47 2006 61 64 (Pubitemid 43005165)
9. D.A. Morrow, and J.A. de Lemos Benchmarks for the assessment of cardiovascular biomarkers Circulation 115 2007 949 952
10. W.F. Peacock IV, T. De Marco, and G.C. Fonarow Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2008 2117 2126 (Pubitemid 351679598)
11. Y. Xue, P. Clopton, W.F. Peacock, and A.S. Maisel Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure Eur J Heart Fail 13 2011 37 42
12. G.C. Fonarow, W.F. Peacock, and T.B. Horwich Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE Am J Cardiol 101 2008 231 237
13. W. Miller, K.A. Hartman, and M.F. Burrritt Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 2007 249 257 (Pubitemid 47196560)
14. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 2006 112 119 (Pubitemid 43032474)
15. A. Maisel, C. Mueller, and R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
16. A.S. Maisel, Y. Xue, and K. Shah Increased 90-day mortality in acute heart failure patients with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study Circ Heart Fail 4 2011 613 620
17. S.R. Goldsmith, G.S. Francis, A.W. Cowley Jr., T.B. Levine, and J.N. Cohn Increased plasma arginine vasopressin levels in patients with congestive heart failure J Am Coll Cardiol 1 1983 1385 1390 (Pubitemid 13054124)
18. M. Domanski, S. Pocock, and C. Bernaud Surrogate endpoints in randomized cardiovascular clinical trials Fundam Clin Pharmacol 25 2011 411 413